Madrid, Spain and Heidelberg, Germany, November 21, 2014 - SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) , announced today the attendance at two major German investor conferences in November and December 2014.
German Equity Forum hosted by Deutsche Börse AG
Date of attendance: 25 and 26 November 2014
Presentation time: Tuesday, 25 November 2014, 15:00 - 15:30 pm CET, Room London
Venue: Frankfurt/Main, Germany, Congress Center Messe Frankfurt
Presenting and available for meetings: Pilar de la Huerta, CEO/CFO
More information: http://www.eigenkapitalforum.com/
18th Munich Capital Markets Conference (MKK) hosted by GBC AG
Date of attendance: 9 December 2014
Presentation time: Tuesday, 9 December 2014, 12:20 - 13:00 pm CET, Room GBC III
Venue: Munich, Germany, The Charles Hotel
Presentation at the MC Services HealthCare Forum and available for meetings: Pilar de la Huerta, CEO/CFO
More information: http://www.mkk-investor.de/
If you would like to meet us please contact for both conferences: contact@mc-services.eu or via phone: +49 89 210 228-0.
For further information please contact:
SYGNIS AG
Pilar de la Huerta
CEO/CFO
Phone: +34 91 192 36 50
Email: pdelahuerta@sygnis.es
About SYGNIS AG: www.sygnis.com
Following the merger with X-Pol Biotech in 2012, SYGNIS specializes on the development and commercialization of products for DNA amplification and sequencing. SYGNIS AG, listed at the German Stock Exchange (Prime Standard segment, Tick: LIO1; ISIN: DE000A1RFM03), has a commercial product for whole genome DNA amplification, SensiPhi (R) , licensed to an industry leading partner and is currently developing its own TruePrime(TM) product line based on its proprietary PrimPol technology for use in the fast growing field of Next Generation Sequencing. The first product for single cell DNA amplification is expected to be launched in January 2015.
Help employers find you! Check out all the jobs and post your resume.
German Equity Forum hosted by Deutsche Börse AG
Date of attendance: 25 and 26 November 2014
Presentation time: Tuesday, 25 November 2014, 15:00 - 15:30 pm CET, Room London
Venue: Frankfurt/Main, Germany, Congress Center Messe Frankfurt
Presenting and available for meetings: Pilar de la Huerta, CEO/CFO
More information: http://www.eigenkapitalforum.com/
18th Munich Capital Markets Conference (MKK) hosted by GBC AG
Date of attendance: 9 December 2014
Presentation time: Tuesday, 9 December 2014, 12:20 - 13:00 pm CET, Room GBC III
Venue: Munich, Germany, The Charles Hotel
Presentation at the MC Services HealthCare Forum and available for meetings: Pilar de la Huerta, CEO/CFO
More information: http://www.mkk-investor.de/
If you would like to meet us please contact for both conferences: contact@mc-services.eu or via phone: +49 89 210 228-0.
For further information please contact:
SYGNIS AG
Pilar de la Huerta
CEO/CFO
Phone: +34 91 192 36 50
Email: pdelahuerta@sygnis.es
About SYGNIS AG: www.sygnis.com
Following the merger with X-Pol Biotech in 2012, SYGNIS specializes on the development and commercialization of products for DNA amplification and sequencing. SYGNIS AG, listed at the German Stock Exchange (Prime Standard segment, Tick: LIO1; ISIN: DE000A1RFM03), has a commercial product for whole genome DNA amplification, SensiPhi (R) , licensed to an industry leading partner and is currently developing its own TruePrime(TM) product line based on its proprietary PrimPol technology for use in the fast growing field of Next Generation Sequencing. The first product for single cell DNA amplification is expected to be launched in January 2015.
Help employers find you! Check out all the jobs and post your resume.
